Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Sander Kersten, … , Béatrice Desvergne, Walter Wahli
Sander Kersten, … , Béatrice Desvergne, Walter Wahli
Published June 1, 1999
Citation Information: J Clin Invest. 1999;103(11):1489-1498. https://doi.org/10.1172/JCI6223.
View: Text | PDF
Article

Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  • Text
  • PDF
Abstract

Prolonged deprivation of food induces dramatic changes in mammalian metabolism, including the release of large amounts of fatty acids from the adipose tissue, followed by their oxidation in the liver. The nuclear receptor known as peroxisome proliferator–activated receptor α (PPARα) was found to play a role in regulating mitochondrial and peroxisomal fatty acid oxidation, suggesting that PPARα may be involved in the transcriptional response to fasting. To investigate this possibility, PPARα-null mice were subjected to a high fat diet or to fasting, and their responses were compared with those of wild-type mice. PPARα-null mice chronically fed a high fat diet showed a massive accumulation of lipid in their livers. A similar phenotype was noted in PPARα-null mice fasted for 24 hours, who also displayed severe hypoglycemia, hypoketonemia, hypothermia, and elevated plasma free fatty acid levels, indicating a dramatic inhibition of fatty acid uptake and oxidation. It is shown that to accommodate the increased requirement for hepatic fatty acid oxidation, PPARα mRNA is induced during fasting in wild-type mice. The data indicate that PPARα plays a pivotal role in the management of energy stores during fasting. By modulating gene expression, PPARα stimulates hepatic fatty acid oxidation to supply substrates that can be metabolized by other tissues.

Authors

Sander Kersten, Josiane Seydoux, Jeffrey M. Peters, Frank J. Gonzalez, Béatrice Desvergne, Walter Wahli

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Fasting-induced gross disturbances in the levels of several plasma metab...
Fasting-induced gross disturbances in the levels of several plasma metabolite levels in PPARα-null mice. SV129 wild-type or PPARα-null mice were sacrificed at the end of the dark cycle (fed state) or after a 24-hour fast that was started at the beginning of the light cycle (fasted state). (a) Plasma FFA concentrations. (b) Plasma β-hydroxybutyrate concentrations. (c) Plasma lactate concentrations. (d) Glycogen concentrations in liver. Error bars represent SEM. For the data in a–c, ANOVA yielded a significant effect for fasting vs. feeding (P < 0.01). For the data in a and b, the same was true for genotype and for the interaction between fasting/feeding and genotype (P < 0.01). §Significantly different from fed wild-type mice (P < 0.05). *Significantly different from all other values (P < 0.01). †Significantly different from fed mice (P < 0.01). All analyses by post hoc t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts